Clinical Trials Directory

Trials / Unknown

UnknownNCT02893046

HCV Care Pathway in Ile-de-France

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of this research is to evaluate a care pathway adapted to different category populations at risk of being infected with the hepatitis C virus in order to improve both the diagnosis turnaround times and the access to treatment. The aim is to allow a quick and effective access to diagnosis and treatment of HCV by strengthening the city hospital networks, access to early consultations and coordination of medical social actors.

Detailed description

The current estimation of infected persons with chronic hepatitis C in France is over 200 ,000. It appears that prevention, screening, care management, medical and social care of patients can be significantly improved especially among the most vulnerable populations. Indeed, these new HCV infections are mediated by drug-using people, prisoners, migrants, men who have sex with men (MSM) and who are supported too late and without real access to treatment.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2016-09-01
Primary completion
2017-09-01
Completion
2019-09-01
First posted
2016-09-08
Last updated
2016-09-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02893046. Inclusion in this directory is not an endorsement.